Alpha-Ketoglutarate for Anti-Aging: The Human RCT

Alpha-ketoglutarate (AKG) is a Krebs cycle intermediate that serves as a critical metabolic hub — it participates in energy production, nitrogen metabolism, and crucially, as a cofactor for a family of enzymes that regulate epigenetic marks on DNA. AKG declines substantially with age, and a 2021 randomized controlled trial found that supplementing with calcium alpha-ketoglutarate reversed biological age by approximately eight years on the Horvath epigenetic clock. This makes it one of the most compelling longevity supplements with direct human evidence.

What Is Alpha-Ketoglutarate?

AKG (also called 2-oxoglutarate) is produced in the citric acid cycle from isocitrate and is converted to succinyl-CoA. It serves as a nitrogen carrier, a precursor for glutamate and proline synthesis, and as a required cofactor for dioxygenase enzymes. Blood AKG levels decline roughly 10-fold between youth and old age, a decline that mirrors NAD+ and spermidine as a recurring theme in longevity biology.

The TET Enzyme and Epigenetic Age

The mechanism connecting AKG to biological aging runs through the TET family of enzymes (TET1, TET2, TET3). TET enzymes catalyze the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), the first step in active DNA demethylation. This process is required for resetting aberrant methylation patterns — the type of methylation drift that epigenetic clocks detect as biological aging.

TET enzymes require alpha-ketoglutarate as a cofactor (along with oxygen and iron). When AKG declines with age, TET activity falls and the genome drifts toward the hypermethylated, aged methylation pattern. Supplementing with AKG essentially provides more cofactor for these DNA demethylation reactions, theoretically enabling TET enzymes to maintain a more youthful epigenetic state.

mTOR Inhibition: A Second Mechanism

AKG also inhibits mTOR (mechanistic target of rapamycin) activity — the nutrient-sensing pathway whose inhibition is one of the most robust interventions for lifespan extension in model organisms. AKG competes with succinate for binding to prolyl hydroxylases, which activates hypoxia-inducible factor (HIF), which in turn reduces mTOR activity.

In C. elegans, AKG supplementation extends lifespan by 50%, primarily through mTOR pathway inhibition. In mice, AKG supplementation delayed multiple aging phenotypes including hair loss, spinal curvature, and frailty scores.

The Rejuvant Human RCT

The landmark human trial tested Rejuvant (calcium alpha-ketoglutarate, 1,000 mg/day) against placebo in 42 adults aged 40-72 for seven months. The study, published in Aging (2021), measured biological age at baseline and endpoint using the Horvath DNA methylation clock from blood samples.

Results: the AKG group showed an average biological age reduction of 7.9 years compared to placebo. Fourteen participants in the AKG group showed biological age reductions greater than 10 years. No significant adverse effects were observed. The most pronounced effects were in older participants, who showed greater responses than younger participants in the cohort.

This remains one of the most dramatic single-compound epigenetic age reversal results in a human RCT. Important caveats: the study was small (n=42), short-term (7 months), and the Horvath clock, while validated, measures one dimension of biological aging.

Calcium vs. Other Salt Forms

The Rejuvant trial used the calcium salt of AKG, which is stable and has reasonable bioavailability. Other forms include AKG combined with arginine (arg-AKG, common in pre-workout supplements) or sodium-AKG. The arginine combination is taken for different reasons (nitric oxide production) and delivers lower AKG doses than the calcium form. For longevity purposes, pure calcium-AKG at 1,000-1,500 mg/day is the relevant form.

Practical Dosing and Timing

The trial used 1,000 mg/day. Some practitioners use 1,500-2,000 mg/day for potentially greater TET enzyme activation, though dose-response data in humans is limited. AKG has a short half-life, so dividing the dose (500 mg morning, 500 mg evening) may maintain more stable serum levels than a single dose.

AKG is best taken away from protein-containing meals, as amino acid competition may reduce absorption. Taking it 30-60 minutes before meals or on an empty stomach is a practical approach.

Synergistic Combinations

AKG pairs well with other epigenetic-focused supplements. Combining it with NMN (which provides NAD+ for sirtuin-mediated histone deacetylation) and spermidine (which influences histone acetylation through EP300 inhibition) addresses multiple epigenetic mechanisms simultaneously.

FAQ

Q: How quickly does AKG show effects on epigenetic age?

The Rejuvant trial showed meaningful changes at 7 months. Shorter intervals may show modest changes, but epigenetic clocks reflect months-long integration of cellular state.

Q: Can I get AKG from food?

AKG is found in small amounts in fermented foods, wine, and some vegetables, but dietary intake is insufficient to meaningfully raise plasma levels. Supplemental calcium-AKG is necessary for the doses studied.

Q: Should I combine AKG with vitamin C?

Vitamin C is also a cofactor for TET enzymes (as an electron donor to restore the iron cofactor). Combining AKG with adequate vitamin C may enhance TET activity. This combination has not been tested in human trials but is mechanistically logical.

Track your supplements in Optimize.